Search Results - "Mohorcic, Katja"

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program by Illini, Oliver, Hochmair, Maximilian Johannes, Fabikan, Hannah, Weinlinger, Christoph, Tufman, Amanda, Swalduz, Aurélie, Lamberg, Kristina, Hashemi, Sayed M. S., Huemer, Florian, Vikström, Anders, Wermke, Martin, Absenger, Gudrun, Addeo, Alfredo, Banerji, Shantanu, Calles, Antonio, Clarke, Stephen, Di Maio, Massimo, Durand, Alice, Duruisseaux, Michaël, Itchins, Malinda, Kääränien, Okko-Sakari, Krenn, Florian, Laack, Eckart, de Langen, Adrianus Johannes, Mohorcic, Katja, Pall, Georg, Passaro, Antonio, Prager, Gerald, Rittmeyer, Achim, Rothenstein, Jeffrey, Schumacher, Michael, Wöll, Ewald, Valipour, Arschang

“…Introduction: Rearranged during transfection (RET) gene fusions are rare genetic drivers in non-small cell lung cancer (NSCLC). Selective RET-inhibitors such…”
Get full text

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis by Illini, Oliver, Saalfeld, Felix Carl, Christopoulos, Petros, Duruisseaux, Michaël, Vikström, Anders, Peled, Nir, Demedts, Ingel, Dudnik, Elizabeth, Eisert, Anna, Hashemi, Sayed M S, Janzic, Urska, Kian, Waleed, Mohorcic, Katja, Mohammed, Saara, Silvoniemi, Maria, Rothschild, Sacha I, Schulz, Christian, Wesseler, Claas, Addeo, Alfredo, Armster, Karin, Itchins, Malinda, Ivanović, Marija, Kauffmann-Guerrero, Diego, Koivunen, Jussi, Kuon, Jonas, Pavlakis, Nick, Piet, Berber, Sebastian, Martin, Velthaus-Rusik, Janna-Lisa, Wannesson, Luciano, Wiesweg, Marcel, Wurm, Robert, Albers-Leischner, Corinna, Aust, Daniela E, Janning, Melanie, Fabikan, Hannah, Herold, Sylvia, Klimova, Anna, Loges, Sonja, Sharapova, Yana, Schütz, Maret, Weinlinger, Christoph, Valipour, Arschang, Overbeck, Tobias Raphael, Griesinger, Frank, Jakopovic, Marko, Hochmair, Maximilian J, Wermke, Martin

“…EGFR exon 20 (EGFR Ex20) insertion mutations in non-small cell lung cancer (NSCLC) are insensitive to traditional EGFR tyrosine kinase inhibitors (TKIs)…”
Get full text

Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes by Janzic, Urska, Janzic, Andrej, Agbarya, Abed, Bidovec-Stojkovic, Urska, Mohorcic, Katja, Caks, Marina, Korosec, Peter, Rijavec, Matija, Skof, Erik

“…Due to the devastating COVID-19 pandemic, a preventive tool in the form of vaccination was introduced. Thoracic cancer patients had one of the highest rates of…”
Get full text

A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers by Janzic, Urska, Bidovec-Stojkovic, Urska, Korosec, Peter, Mohorcic, Katja, Mrak, Loredana, Caks, Marina, Ravnik, Maja, Skof, Erik, Rijavec, Matija

“…The recommended booster third dose of vaccination against COVID-19 in cancer patients seems reasonable to protect them against a severe disease course. A…”
Get full text

Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis by Ljubicic, Lidija, Janzic, Urska, Unk, Mojca, Terglav, Ana Sophie, Mohorcic, Katja, Seiwerth, Fran, Bitar, Lela, Badovinac, Sonja, Plestina, Sanja, Korsic, Marta, Kukulj, Suzana, Samarzija, Miroslav, Jakopovic, Marko

“…Abstract Background The standard first-line systemic treatment for patients with non-oncogene addicted advanced nonsquamous non-small cell lung cancer (NSCLC)…”
Get full text

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program by Illini, Oliver, Fabikan, Hannah, Swalduz, Aurélie, Vikström, Anders, Krenbek, Dagmar, Schumacher, Michael, Dudnik, Elizabeth, Studnicka, Michael, Öhman, Ronny, Wurm, Robert, Wannesson, Luciano, Peled, Nir, Kian, Waleed, Bar, Jair, Daher, Sameh, Addeo, Alfredo, Rotem, Ofer, Pall, Georg, Zer, Alona, Saad, Akram, Cufer, Tanja, Sorotsky, Hadas Gantz, Hashemi, Sayed M. S., Mohorcic, Katja, Stoff, Ronen, Rovitsky, Yulia, Keren-Rosenberg, Shoshana, Winder, Thomas, Weinlinger, Christoph, Valipour, Arschang, Hochmair, Maximilian J.

“…Background: Patients with non-small cell lung cancer (NSCLC) presenting with mesenchymal–epithelial transition (MET) exon 14 skipping mutation have an…”
Get full text

Highly efficient automated extraction of DNA from old and contemporary skeletal remains by Zupanič Pajnič, Irena, Debska, Magdalena, Gornjak Pogorelc, Barbara, Vodopivec Mohorčič, Katja, Balažic, Jože, Zupanc, Tomaž, Štefanič, Borut, Geršak, Ksenija

“…Abstract We optimised the automated extraction of DNA from old and contemporary skeletal remains using the AutoMate Express system and the PrepFiler BTA kit…”
Get full text

Expansion of pulmonary CD8+CD56+ natural killer T-cells in hypersensitivity pneumonitis by Korosec, Peter, Osolnik, Katarina, Kern, Izidor, Silar, Mira, Mohorcic, Katja, Kosnik, Mitja

“…Natural killer T (NKT) cells, a newly identified subgroup of T cells with immunoregulatory function, may be implicated in the pathogenesis of interstitial lung…”
Get more information

Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity by Vlacic, Gregor, Hoda, Mir A, Klikovits, Thomas, Sinn, Katharina, Gschwandtner, Elisabeth, Mohorcic, Katja, Schelch, Karin, Pirker, Christine, Peter-Vörösmarty, Barbara, Brankovic, Jelena, Dome, Balazs, Laszlo, Viktoria, Cufer, Tanja, Rozman, Ales, Klepetko, Walter, Grasl-Kraupp, Bettina, Hegedus, Balazs, Berger, Walter, Kern, Izidor, Grusch, Michael

“…Malignant pleural mesothelioma (MPM) is a devastating malignancy with limited therapeutic options. Fibroblast growth factor receptors (FGFR) and their ligands…”
Get full text

Reccomendations for diagnosis and treatment of patients with lung cancer by Martina Vrankar, Nina Boc, Izidor Kern, Aleš Rozman, Karmen Stanič, Tomaž Štupnik, Mojca Unk, Maja Ebert Moltara, Vesna Zadnik, Katja Adamič, Jernej Benedik, Marko Bitenc, Jasna But Hadžić, Anton Crnjac, Eva Ćirić, Tanja Čufer, Goran Gačevski, Marta Globočnik Kukovica, Kristina Gornik Kramberger, Maja Ivanetič Pantar, Staša Jelerčič, Veronika Kloboves Prevodnik, Mile Kovačevič, Luka Ležaić, Mateja Marc Malovrh, Katja Mohorčič, Bogdan Vidmar, Dušanka Vidovič, Gregor Vlačič, Ana Lina Vodušek, Rok Zbačnik, Ivana Žagar

Get full text

Booster third dose of SARS-CoV-2 vaccine effectively lifts the waning immune response of solid cancer patients by Janzic, Urska, Bidovec-Stojkovic, Urska, Katja, Mohorcic, Fokter Dovnik, Nina, Caks, Marina, Debeljak, Jerneja, Korosec, Peter, Rijavec, Matija

“…e18791 Background: Since cancer patients (pts) are at increased risk of severe morbidity and mortality due to COVID-19, SARS-CoV-2 vaccination is crucial to…”
Get full text

Immunophenotypes of anti-SARS-CoV-2 responses associated with fatal COVID-19 by Šelb, Julij, Bitežnik, Barbara, Bidovec Stojković, Urška, Rituper, Boštjan, Osolnik, Katarina, Kopač, Peter, Svetina, Petra, Cerk Porenta, Kristina, Šifrer, Franc, Lorber, Petra, Trinkaus Leiler, Darinka, Hafner, Tomaž, Jerič, Tina, Marčun, Robert, Lalek, Nika, Frelih, Nina, Bizjak, Mojca, Lombar, Rok, Nikolić, Vesna, Adamič, Katja, Mohorčič, Katja, Grm Zupan, Sanja, Šarc, Irena, Debeljak, Jerneja, Koren, Ana, Luzar, Ajda Demšar, Rijavec, Matija, Kern, Izidor, Fležar, Matjaž, Rozman, Aleš, Korošec, Peter

“…The relationship between anti-SARS-CoV-2 humoral immune response, pathogenic inflammation, lymphocytes and fatal COVID-19 is poorly understood. A longitudinal…”
Get full text

Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination by Janzic, Urska, Bidovec-Stojkovic, Urska, Mohorcic, Katja, Mrak, Loredana, Dovnik, Nina Fokter, Ivanovic, Marija, Ravnik, Maja, Caks, Marina, Skof, Erik, Debeljak, Jerneja, Korosec, Peter, Rijavec, Matija

“…SARS-CoV-2 vaccination in cancer patients is crucial to prevent severe COVID-19 disease course. This study assessed immunogenicity of cancer patients on active…”
Get full text

Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup by Pirker, Christine, Bilecz, Agnes, Grusch, Michael, Mohr, Thomas, Heidenreich, Barbara, Laszlo, Viktoria, Stockhammer, Paul, Lötsch-Gojo, Daniela, Gojo, Johannes, Gabler, Lisa, Spiegl-Kreinecker, Sabine, Dome, Balazs, Steindl, Ariane, Klikovits, Thomas, Hoda, Mir Alireza, Jakopovic, Marko, Samarzija, Miroslav, Mohorcic, Katja, Kern, Izidor, Kiesel, Barbara, Brcic, Luka, Oberndorfer, Felicitas, Müllauer, Leonhard, Klepetko, Walter, Schmidt, Wolfgang M, Kumar, Rajiv, Hegedus, Balazs, Berger, Walter

“…Human malignant pleural mesothelioma (MPM) is characterized by dismal prognosis. Consequently, dissection of molecular mechanisms driving malignancy is of key…”
Get full text

A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial by Peters, Solange, Danson, Sarah, Hasan, Baktiar, Dafni, Urania, Reinmuth, Niels, Majem, Margarita, Tournoy, Kurt G, Mark, Michael T, Pless, Miklos, Cobo, Manuel, Rodriguez-Abreu, Delvys, Falchero, Lionel, Moran, Teresa, Ortega Granados, Ana Laura, Monnet, Isabelle, Mohorcic, Katja, Sureda, Bartomeu Massutí, Betticher, Daniel, Demedts, Ingel, Macias, Jose Antionio, Cuffe, Sinead, Luciani, Andrea, Sanchez, Jose Garcia, Curioni-Fontecedro, Alessandra, Gautschi, Oliver, Price, Gillian, Coate, Linda, von Moos, Roger, Zielinski, Christoph, Provencio, Mariano, Menis, Jessica, Ruepp, Barbara, Pochesci, Alessia, Roschitzki-Voser, Heidi, Besse, Benjamin, Rabaglio, Manuela, O'Brien, Mary E R, Stahel, Rolf A

“…Receptor activator of NF-kB ligand stimulates NF-kB-dependent cell signaling and acts as the primary signal for bone resorption. Retrospective analysis of a…”
Get more information

Future perspective for the application of predictive biomarkertesting in advanced stage non-small cell lung cance by de Jager, Vincent D., Timens, Wim, Bayle, Arnaud, Botling, Johan, Brcic, Luka, Buettner, Reinhard, Fernandes, Maria Gabriela O., Havel, Libor, Hochmair, Maximilian, Hofman, Paul, Janssens, Annelies, van Kempe, Leon, Kern, Izidor, Machado, Jose Carlos, Mohorcic, Katja, Popat, Sanjay, Ryska, Ales, Wolf, Juergen, Schuuring, Ed, van der Wekken, Anthonie J.

“…For patients with advanced stage non-small cell lung cancer (NSCLC), treatment strategies have changed significantly due to the introduction of targeted…”
Get full text

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries by de Jager, Vincent D., Timens, Wim, Bayle, Arnaud, Botling, Johan, Brcic, Luka, Büttner, Reinhard, Fernandes, Maria Gabriela O., Havel, Libor, Hochmair, Maximilian J., Hofman, Paul, Janssens, Annelies, Johansson, Mikael, van Kempen, Léon, Kern, Izidor, Lopez-Rios, Fernando, Lüchtenborg, Margreet, Machado, José Carlos, Mohorcic, Katja, Paz-Ares, Luis, Popat, Sanjay, Ryška, Aleš, Taniere, Phillipe, Wolf, Jürgen, Schuuring, Ed, van der Wekken, Anthonie J.

“…In the past two decades, the treatment of metastatic non-small cell lung cancer (NSCLC), has undergone significant changes due to the introduction of targeted…”
Get full text

Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study by Brcic, Luka, Klikovits, Thomas, Megyesfalvi, Zsolt, Mosleh, Berta, Sinn, Katharina, Hritcu, Richard, Laszlo, Viktoria, Cufer, Tanja, Rozman, Ales, Kern, Izidor, Mohorcic, Katja, Jakopovic, Marko, Samarzija, Miroslav, Seiwerth, Sven, Kolek, Vitezslav, Fischer, Ondřej, Jakubec, Petr, Škarda, Jozef, Gieszer, Balazs, Hegedus, Balazs, Fillinger, Janos, Renyi-Vamos, Ferenc, Buder, Anna, Bilecz, Agnes, Berger, Walter, Grusch, Michael, Hoetzenecker, Konrad, Klepetko, Walter, Hoda, Mir Alireza, Filipits, Martin, Dome, Balazs

Get full text

Advancements in Non-Small Cell Lung Cancer Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries by Jager, Vincent D. de, Timens, Wim, Bayle, Arnaud, Botling, Johan, Brcic, Luka, Buettner, Reinhard, Fernandes, Maria Gabriela O., Havel, Libor, Hochmair, Maximilian J., Hofman, Paul, Janssens, Annelies, Johansson, Mikael, van Kempen, Leon, Kern, Izidor, Lopez-Rios, Fernando, Luchtenborg, Margreet, Machado, Jose Carlos, Mohorcic, Katja, Paz-Ares, Luis, Popat, Sanjay, Ryska, Ales, Taniere, Phillipe, Wolf, Juergen, Schuuring, Ed, van der Wekkenz, Anthonie J.

“…In the past two decades, the treatment of metastatic non -small cell lung cancer (NSCLC), has undergone significant changes due to the introduction of targeted…”
Get full text

Real-world experience with capmatinib in exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program by Oliver Illini, Hannah Fabikan, Aurélie Swalduz, Anders Vikström, Dagmar Krenbek, Michael Schumacher, Elizabeth Dudnik, Michael Studnicka, Ronny Öhman, Robert Wurm, Luciano Wannesson, Nir Peled, Waleed Kian, Jair Bar, Sameh Daher, Alfredo Addeo, Ofer Rotem, Georg Pall, Alona Zer, Akram Saad, Tanja Cufer, Hadas Gantz Sorotsky, Sayed M. S. Hashemi, Katja Mohorcic, Ronen Stoff, Yulia Rovitsky, Shoshana Keren-Rosenberg, Thomas Winder, Christoph Weinlinger, Arschang Valipour, Maximilian J. Hochmair

“…Background: Patients with non-small cell lung cancer (NSCLC) presenting with mesenchymal–epithelial transition ( MET ) exon 14 skipping mutation have an…”
Get full text